Micron Technology has now fallen 15% on the week and 28% over the past month, trading at $820.53, as the CXMT-driven pressure documented last week continues to compound — and CEO Sanjay Mehrotra chose July 24 to sell roughly $13.1 million of stock near the highs.
The insider angle is the most striking wrinkle in an otherwise familiar story. Mehrotra executed ten separate sell transactions on July 24, offloading roughly 13,800 shares at prices between $915 and $940 — well above Tuesday's close. The sales arrived the same week the stock broke back below $850. Whether these were pre-scheduled plan sales or discretionary, the timing will draw scrutiny. The 90-day net across all insiders is a positive $29 million, suggesting no broader exodus, but a CEO sell of this size during an already-pressured tape is the kind of signal that tends to stick in market memory.
The positioning picture has changed since last week's note, and not in the direction bulls would want. Short interest held near 3.24% of free float — unchanged from the 5.4-million-share jump recorded on July 24 that the prior article flagged. That level is modest in absolute terms, but the 17% weekly rise confirms shorts are not covering into weakness. The borrow market remains effectively unconstricted: availability is at maximum, cost to borrow is running just 0.31%, and the lending pool shows no sign of tightening. Shorts face no structural squeeze pressure whatsoever.
Options positioning has turned notably less defensive than its recent peak, which itself marks a divergence worth naming. The put/call ratio is at 1.27, more than 1.5 standard deviations below its 20-day average of 1.35 and well off the 52-week high of 1.44 hit just last week. That is the inverse of what you might expect given the price action — traders who rushed into downside protection at the top of the recent bounce appear to have unwound those hedges even as the stock continued falling. The options market is not panicking; it may simply be exhausted from hedging a name that has moved 15-30% in either direction repeatedly over the past month.
The Street's structural bull case remains intact, though the gap between price and target has widened further. The consensus points to a mean target near $1,507 — nearly double the current price — with the cluster of post-earnings upgrades from late June still on record. Keybanc raised its target to $1,750 on July 14, the most recent change. Goldman Sachs remains the outlier at $1,100 with a Neutral rating, but even that implies 34% upside from here. EPS momentum ranks in the 94th percentile on both 30- and 90-day windows. The PE multiple has compressed to 6.9x on a trailing basis, down over three full turns in a month, and EV/EBITDA has fallen to 5.6x — valuation that would look cheap in almost any other sector cycle. The bear case centres on the same structural concern it always has: DRAM and NAND pricing vulnerability if AI-driven demand disappoints or CXMT accelerates market share erosion faster than the cycle can absorb.
Peer context underscores that this is sector-wide pain, not a MU-specific collapse. AMKR is the worst performer in the group, down 31% on the week and 25% on Tuesday alone. LRCX and AMD each dropped roughly 16% on the week. COHU fell 24%. The breadth of the selloff makes a single-stock short thesis harder to sustain — and with borrow availability essentially unlimited, the 3.2% SI % FF looks like a measured, deliberate position rather than a crowded directional bet.
The next scheduled catalyst is a Q4 earnings print on September 30. Between now and then, the question is whether Mehrotra's July 24 sales were routine plan transactions or a more meaningful signal — and whether the options market's relative calm reflects genuine stabilisation or simply a pause before the next wave of hedging demand arrives.
See the live data behind this article on ORTEX.
Open MU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.